Alan Williams
Direttore operativo presso Adela, Inc.
Posizioni attive di Alan Williams
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
Adela, Inc.
 Adela, Inc. Finance/Rental/LeasingFinance Adela, Inc. is a company that is developing technology to accelerate the diagnosis and improve the management of cancer through blood tests for minimal residual disease (MRD) monitoring and multi-cancer early detection (MCED). The company is based in Branford, CT. The company's genome-wide methylome enrichment platform captures extensive, biologically-relevant genomic information to maximize test performance and improve treatment decisions. Adela's approach to MRD testing is tissue agnostic, eliminating the burden of acquiring a tumor sample. The CEO of the company is Scott Bratman. | Direttore operativo | 11/05/2023 | - |
Storia della carriera di Alan Williams
Precedenti posizioni note di Alan Williams
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| STANDARD BIOTOOLS INC. | Corporate Officer/Principal | 01/01/2020 | 01/03/2023 |
| THERMO FISHER SCIENTIFIC | Corporate Officer/Principal | 01/02/2014 | 01/04/2015 |
| AFFYMETRIX, INC. | Corporate Officer/Principal | 01/03/2009 | 01/03/2010 |
Formazione di Alan Williams
| University of California, Davis | Undergraduate Degree |
| University of California, Riverside | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
Posizioni
| Corporate Officer/Principal | 3 |
| Undergraduate Degree | 1 |
| Doctorate Degree | 1 |
Settori
| Health Technology | 3 |
| Consumer Services | 3 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| THERMO FISHER SCIENTIFIC | Health Technology |
| STANDARD BIOTOOLS INC. | Commercial Services |
| Aziende private | 2 |
|---|---|
Affymetrix, Inc.
 Affymetrix, Inc. Medical SpecialtiesHealth Technology Affymetrix, Inc. develops, manufactures and sells products and services for genetic analysis. The company was founded by Stephen P. A. Fodor in 1992 and is headquartered in Santa Clara, CA. | Health Technology |
Adela, Inc.
Adela, Inc. Finance/Rental/LeasingFinance Adela, Inc. is a company that is developing technology to accelerate the diagnosis and improve the management of cancer through blood tests for minimal residual disease (MRD) monitoring and multi-cancer early detection (MCED). The company is based in Branford, CT. The company's genome-wide methylome enrichment platform captures extensive, biologically-relevant genomic information to maximize test performance and improve treatment decisions. Adela's approach to MRD testing is tissue agnostic, eliminating the burden of acquiring a tumor sample. The CEO of the company is Scott Bratman. | Finance |
- Borsa valori
- Insiders
- Alan Williams
- Esperienza
